Influenza vaccination status ascertainment and vaccine effectiveness estimation: validity of self-report for current and prior season
Peredo, R.; Savard, N.; Separovic, L.; Zhan, Y.; Amini, R.; Kiely, M.; Carazo, S.; Skowronski, D. M.
Show abstract
Accurate vaccination status ascertainment is fundamental to valid vaccine effectiveness (VE) estimation. We evaluated the accuracy of current and prior seasons self-reported influenza vaccination status among outpatients with acute respiratory illness recruited by the Canadian Sentinel Practitioner Surveillance Network (SPSN) during the 2023-2024 season in Quebec, Canada. Vaccination status was self-reported at specimen collection for influenza virus testing and compared to the provincial vaccination registry. Self-report showed high registry agreement, including sensitivity, specificity, accuracy and kappa statistics for current (91%, 98%, 96%, 0.89) and prior (85%, 95%, 92%, 0.78) seasons vaccination status. Metrics were similar by influenza case status, age, sex and comorbidity with more variation for sensitivity than specificity. Test-negative design estimates of the crude association between influenza case status and current seasons self-reported or registry-based vaccination status did not meaningfully differ, with absolute difference of 2% overall. Findings support self-reported influenza vaccination for timely and valid VE estimation.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Agreement between state registry, health record, and self-report of influenza vaccination 97%
- Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza season 95%
- Determinants of SARS-CoV-2 IgG response and decay in Canadian healthcare workers: a prospective cohort study 93%
Similar papers in this journal
- Using Capture-Recapture Methods to Estimate Influenza Hospitalization Incidence Rates 95%
- Vaccine Effectiveness against COVID-19 among Symptomatic Persons Aged ≥12 Years with Reported Contact with COVID-19 Cases, February – September 2021 93%
- Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network 93%
Similar papers in this journal
- Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada 94%
- The Nicaraguan Pediatric Influenza Cohort Study, 2011-2019: influenza incidence, seasonality, and transmission 94%
- Effectiveness of Influenza Vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection? 94%
Similar papers in this journal
- Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: impact of variant replacement and waning protection during 10-month follow-up 93%
- Risk of Coronavirus Disease 2019 (COVID-19) among Those Up-to-Date and Not Up-to-Date on COVID-19 Vaccination 93%
- The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.